Knee Cartilage Repair Insurance Denied? How to Appeal

Insurance companies deny knee cartilage repair claims at high rates — particularly for newer biologics-based procedures like Matrix-Associated Autologous Chondrocyte Implantation (MACI) and osteochondral allograft transplantation. These denials often rest on "experimental" or "not medically necessary" determinations that directly contradict published orthopedic guidelines. Here is how to challenge them effectively.

Why Insurers Deny Knee Cartilage Repair Claims

Knee cartilage repair denials follow distinct patterns based on the procedure involved:

• Not medically necessary — The insurer's reviewer determines the cartilage defect does not meet its clinical criteria for surgical intervention, often citing defect size thresholds, patient age, or BMI requirements that differ from AAOS or International Cartilage Regeneration and Joint Preservation Society (ICRS) standards
• Experimental or investigational — MACI (FDA-approved in 2016), osteochondral allograft transplantation, and autologous chondrocyte implantation (ACI) are sometimes classified as investigational despite FDA approval and substantial peer-reviewed evidence
• Conservative treatment not exhausted — Insurers frequently require documented failure of physical therapy, NSAIDs, intra-articular injections, and activity modification before approving cartilage repair procedures
• Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization not obtained — Cartilage repair procedures almost universally require pre-authorization; missing or expired authorization results in denial regardless of medical necessity
• Lesion size criteria not met — Some insurer policies specify minimum defect size (e.g., ≥2 cm²) for coverage of MACI or osteochondral procedures; appeal documentation must include MRI-based defect size measurement
• Age or activity level exclusions — Some policies apply age cutoffs or exclude patients they classify as "too active" or "too sedentary" for the procedure; these criteria are not supported by AAOS guidelines

Under ACA §2719 and ERISA §1133, you have the right to a written denial explanation, internal appeal, and independent External Independent Review: Complete Guide" class="auto-link">external review.

How to Appeal a Knee Cartilage Repair Denial

Step 1: Read Your Denial Letter and Request the Insurer's Clinical Policy

Contact the insurer and request the specific clinical policy bulletin for the denied procedure. Under ERISA §1133 and ACA §2719, this is your legal right. For MACI specifically, also request the FDA Biologics License Application (BLA) approval documentation — FDA approval in December 2016 makes classification as "experimental" untenable.

Step 2: Gather MRI-Based Documentation of the Cartilage Defect

Your appeal must include MRI findings specifically documenting: the location, size (in cm²), and depth of the cartilage defect (ICRS classification grade); involvement of underlying bone; any associated pathology (meniscal tears, ligament injuries, malalignment); and confirmation that the defect is a focal full-thickness chondral or osteochondral lesion appropriate for the requested procedure. MRI-based defect measurements are essential if the insurer's policy includes minimum defect size criteria.

Step 3: Get Your Orthopedic Surgeon to Write a Medical Necessity Letter Citing AAOS and ICRS Standards

The letter should document your diagnosis, MRI-confirmed defect characteristics, age and activity level supporting a biologically active repair approach, failure of prior conservative treatment, and the specific rationale for the selected procedure. Reference AAOS Clinical Practice Guidelines and ICRS consensus statements supporting surgical cartilage repair for your defect characteristics. For MACI, cite the FDA approval (December 2016) and SUMMIT trial data demonstrating superiority over microfracture at 24 months.

Step 4: For MACI "Experimental" Denials — Cite FDA Approval Directly

MACI (matrix-associated autologous chondrocyte implantation, Vericel Corporation) received traditional FDA approval in December 2016. An insurer classifying FDA-approved MACI as experimental cannot sustain that position. Your appeal letter should cite the FDA Biologics License Application approval date, the approved indication (symptomatic single or multiple full-thickness cartilage defects of the knee in adults), and the SUMMIT pivotal trial data.

Step 5: Request a Peer-to-Peer Review

Your orthopedic surgeon should request a direct peer-to-peer review with the insurer's medical director. Most insurers' initial reviewers are not cartilage surgery specialists. A direct conversation with your surgeon often resolves denials involving complex orthobiologics.

Step 6: Request External Review After an Internal Appeal Denial

Under ACA §2719, after an internal appeal denial you are entitled to independent external review. The external reviewer, an orthopedic surgeon with relevant subspecialty expertise, evaluates your case against AAOS and ICRS standards. External reviews overturn 40–60% of insurer denials.

What to Include in Your Appeal

• Insurance denial letter with the specific reason and policy criteria identified
• Your member ID and claim number
• MRI report with defect size, location, and ICRS classification documented
• Orthopedic surgeon's letter of medical necessity citing AAOS guidelines and ICRS standards
• For MACI: FDA BLA approval documentation and SUMMIT trial data
• Documentation of conservative treatment attempted (PT, injections, NSAIDs) and outcome
• Prior treatment notes and surgical history including prior arthroscopy

Fight Back With ClaimBack

Knee cartilage repair denials — particularly MACI "experimental" denials — are among the most successfully overturned when FDA approval and ICRS/AAOS guideline support are clearly cited. ClaimBack generates a professional appeal letter in 3 minutes. Start your free claim analysis → Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal